GPX4 and small cell lung carcinoma: In contrast, GPX4 levels were dramatically decreased by etoposide in SCLC H446 and H1688 cells (Fig. 1L), and etoposide-reduced cell viability of H446 and H1688 cells was substantially mitigated by overexpression of GPX4 (Fig. 1M).